|
|
Life Science
|
|
Devices, Diagnostics, & Distribution
|
|
New medical technologies and breakthroughs have led to the use of gene-based diagnostics in the detection of diseases. These new diagnostics, driven by genomics and imaging technologies, are leading to a new area of interest, Theranostics. These new tools and therapies will have an impact on the evolving demographics.
Devices that utilize biotechnology are having an impact on the use of more traditional cardiology procedures. New interventional technologies and procedures in particular in the areas of minimally invasive surgery may reduce the use of some traditional techniques. The convergence of medical devices and pharmaceuticals will challenge traditional protocols and create new marketing opportunities along with challenging operations and regulatory issues. New product developments and/or acquisition will speed the development and implementation of these new technologies.
Practice Leaders:
John Baker - Boston
Sue Rossiter - St. Albans
Consultants:
Alice Benson - Boston
Paul Bulteel - London
Michael Burroughs - St. Louis
Kay Chen - Shanghai
Clare Cizek - Minneapolis
Diane Coletti - Boston
John Cornille - New York
Eric Dieny - Shanghai
Supriya Dikshit - Mumbai
Caroline Edwards - Hong Kong**
Jeffrey Golove - New York
John R. Hamilton - Pittsburgh
Sophie Harle - Singapore
Rives Hewitt - Toronto
Sussannah Kelly - Toronto
Donald Kilinski - New York
Victor Kleinman - Palm Beach
Helen Kwok - Shanghai
Victoria Lim - Singapore
Kelvin Ling - Hong Kong**
James Martin - Washington, DC
Tara McKernan - Stamford
John McLean - Chicago***
Mike Nagata - Tokyo
Mercedes Paz - Los Angeles
Kimberley Rice - Princeton
Ruth Stone - St. Albans
Johannes Suciu - Frankfurt
Naomi Tachibana - Tokyo
Phoebe Wan - Hong Kong**
Jeffrey Webb - St. Albans
Jan Westerink - Amsterdam**
Lance Winn - Austin
Shawn Woessner - Minneapolis
Debra Young - Denver
|
|